BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25590058)

  • 1. Influence of serum albumin levels during opioid rotation from morphine or oxycodone to fentanyl for cancer pain.
    Hayashi T; Ikehata S; Matsuzaki H; Yasuda K; Makihara T; Futamura A; Arakawa Y; Kuki R; Fukuura K; Takahashi H; Mori N; Higashiguchi T; Yamadaa S
    Biol Pharm Bull; 2014; 37(12):1860-5. PubMed ID: 25590058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, safety and pharmacokinetic study of a novel fentanyl-containing matrix transdermal patch system in Japanese patients with cancer pain.
    Miyazaki T; Hanaoka K; Namiki A; Ogawa S; Kitajima T; Hosokawa T; Ishida T; Nogami S; Mashimo S
    Clin Drug Investig; 2008; 28(5):313-25. PubMed ID: 18407717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Difference in tolerance to anti-hyperalgesic effect and its molecular mechanisms between chronic treatment with morphine, fentanyl and oxycodone in a chronic pain-like state].
    Satoshi I; Narita M; Ozeki A; Nakamura A; Hashimoto S; Narita M; Kuzumaki N; Uezono Y; Suzuki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Nov; 28(5-6):169-76. PubMed ID: 19108502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy switching in patients receiving long-acting opioids.
    Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
    Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fentanyl tolerance in the treatment of cancer pain: a case of successful opioid switching from fentanyl to oxycodone at a reduced equivalent dose.
    Sutou I; Nakatani T; Hashimoto T; Saito Y
    J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):161-5. PubMed ID: 26095488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid Rotation in Cancer Pain Treatment.
    Schuster M; Bayer O; Heid F; Laufenberg-Feldmann R
    Dtsch Arztebl Int; 2018 Mar; 115(9):135-142. PubMed ID: 29563006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in trends and pattern of strong opioid prescribing in primary care.
    Zin CS; Chen LC; Knaggs RD
    Eur J Pain; 2014 Oct; 18(9):1343-51. PubMed ID: 24756859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of oxycodone/paracetamol for patients with bone-cancer pain: a multicenter, randomized, double-blinded, placebo-controlled trial.
    Sima L; Fang WX; Wu XM; Li F
    J Clin Pharm Ther; 2012 Feb; 37(1):27-31. PubMed ID: 21208247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid doses required for pain management in lung cancer patients with different cholesterol levels: negative correlation between opioid doses and cholesterol levels.
    Huang Z; Liang L; Li L; Xu M; Li X; Sun H; He S; Lin L; Zhang Y; Song Y; Yang M; Luo Y; Loh HH; Law PY; Zheng D; Zheng H
    Lipids Health Dis; 2016 Mar; 15():47. PubMed ID: 26952011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Three-day-type transdermal fentanyl patch conversion by rapid titration method with short-acting oral oxycodone for cancer pain].
    Yamazaki K; Fujio N; Ishikawa N; Watanabe H; Kameyama M
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):405-8. PubMed ID: 22421768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxycodone-induced analgesic effects in a bone cancer pain model in mice.
    Kato A; Minami K; Ito H; Tomii T; Matsumoto M; Orita S; Kihara T; Narita M; Suzuki T
    Oncology; 2008; 74 Suppl 1():55-60. PubMed ID: 18758199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
    Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
    Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile.
    Kuo A; Wyse BD; Meutermans W; Smith MT
    Br J Pharmacol; 2015 Jan; 172(2):532-48. PubMed ID: 24641546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward evidence-based prescribing at end of life: a comparative analysis of sustained-release morphine, oxycodone, and transdermal fentanyl, with pain, constipation, and caregiver interaction outcomes in hospice patients.
    Weschules DJ; Bain KT; Reifsnyder J; McMath JA; Kupperman DE; Gallagher RM; Hauck WW; Knowlton CH
    Pain Med; 2006; 7(4):320-9. PubMed ID: 16898943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Concentrations in Oral Fluid and Plasma in Cancer Patients With Pain.
    Heiskanen T; Langel K; Gunnar T; Lillsunde P; Kalso EA
    J Pain Symptom Manage; 2015 Oct; 50(4):524-32. PubMed ID: 25242020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial.
    Narabayashi M; Saijo Y; Takenoshita S; Chida M; Shimoyama N; Miura T; Tani K; Nishimura K; Onozawa Y; Hosokawa T; Kamoto T; Tsushima T;
    Jpn J Clin Oncol; 2008 Apr; 38(4):296-304. PubMed ID: 18326541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A pilot study of the reduced effects of adverse events caused by oral morphine and oxycodone after rotating to fentanyl patch in patients with metastatic breast cancer].
    Ikeda M; Sonoo H; Kurebayashi J; Oota Y; Fujii S; Shimo T; Mizutou A; Seki M; Saitou W; Yamashita T; Koike Y; Yamamoto Y; Shiiki S; Nakashima K; Tanaka K; Nomura T; Kubo S
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):599-603. PubMed ID: 22504685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Delirium Among Patients Having Cancer Injected With Different Opioids for the First Time.
    Tanaka R; Ishikawa H; Sato T; Shino M; Matsumoto T; Mori K; Omae K; Osaka I
    Am J Hosp Palliat Care; 2017 Jul; 34(6):572-576. PubMed ID: 27034433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in medical use and abuse of opioid analgesics.
    Joranson DE; Ryan KM; Gilson AM; Dahl JL
    JAMA; 2000 Apr; 283(13):1710-4. PubMed ID: 10755497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.